This story was reported by Lizzy Lawrence, Matthew Herper, Isabella Cueto, Elizabeth Cooney, Andrew Joseph, Daniel Payne, and Helen Branswell. For more than a half-century, the Centers for Disease ...

Allison covers what hot startups are getting up to, and who’s financing them. She is also co-host of the weekly biotech podcast, “The Readout Loud.” You can reach Allison on Signal at AllisonDeAngelis ...

Lev’s reporting has explored Americans’ deadly hostility to addiction medications, subpar treatment offered in jails and prisons, shifts in the illicit drug supply and consumption behavior, ...

The Trump administration disclosed plans to reduce state directed payments even more, setting up a probable showdown with ...

President Trump's cuts to foreign aid probably hampered the detection of the Ebola outbreak and the response to it.

China's ascent is forcing U.S. biotech companies and investors to pick a side: Is it an ally or an existential threat?

Jeffery Taubenberger, the acting head of the NIAID, the NIH’s infectious disease institute, is reported to have stepped down.

Far fewer knew that mpox and Zika can also be transmitted sexually. And most respondents understood the main ways that these ...

Supporters worry that a men’s health office created by the Trump administration risks being dismantled by a future Democratic ...

A type of targeted chemotherapy developed by China-based Kelun-Biotech and licensed to Merck cut the risk of tumor ...

Merck-Kelun ADC outperforms Keytruda in trial, a closely watched Parkinson’s drug fails, and more biotech news from The ...

Biogen and Denali said their experimental Parkinson’s therapy failed to slow the degenerative brain disorder in a randomized ...